Goldman Sachs Group Inc Ascendis Pharma A/S Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Goldman Sachs Group Inc holds 490,351 shares of ASND stock, worth $63.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
490,351
Previous 421,551 16.32%
Holding current value
$63.7 Million
Previous $57.5 Million 27.37%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$113.0 - $153.43 $7.77 Million - $10.6 Million
68,800 Added 16.32%
490,351 $73.2 Million
Q2 2024

Aug 13, 2024
SELL
$121.07 - $153.67 $1.88 Million - $2.39 Million
-15,541 Reduced 3.56%
421,551 $57.5 Million
Q1 2024

May 15, 2024
BUY
$123.45 - $159.4 $1.76 Million - $2.27 Million
14,238 Added 3.37%
437,092 $66.1 Million
Q4 2023

Feb 13, 2024
BUY
$86.1 - $127.36 $1.11 Million - $1.64 Million
12,881 Added 3.14%
422,854 $53.3 Million
Q3 2023

May 14, 2024
SELL
$86.5 - $103.97 $1.11 Million - $1.34 Million
-12,881 Reduced 3.05%
409,973 $38.4 Million
Q3 2023

Nov 14, 2023
BUY
$86.5 - $103.97 $1.11 Million - $1.34 Million
12,882 Added 3.24%
409,973 $38.4 Million
Q2 2023

May 14, 2024
SELL
$69.96 - $97.84 $150 Million - $210 Million
-2,151,054 Reduced 84.42%
397,091 $35.4 Million
Q2 2023

Aug 14, 2023
SELL
$69.96 - $97.84 $150 Million - $210 Million
-2,151,054 Reduced 84.42%
397,091 $35.4 Million
Q1 2023

May 14, 2024
BUY
$104.9 - $126.78 $3 Million - $3.63 Million
28,633 Added 1.14%
2,548,145 $273 Million
Q1 2023

May 11, 2023
BUY
$104.9 - $126.78 $3 Million - $3.63 Million
28,633 Added 1.14%
2,548,145 $273 Million
Q4 2022

May 14, 2024
SELL
$99.42 - $131.97 $33.7 Million - $44.7 Million
-338,918 Reduced 11.86%
2,519,512 $308 Million
Q4 2022

Feb 13, 2023
SELL
$99.42 - $131.97 $33.7 Million - $44.7 Million
-338,918 Reduced 11.86%
2,519,512 $308 Million
Q3 2022

May 14, 2024
SELL
$84.03 - $110.23 $38.5 Million - $50.5 Million
-457,785 Reduced 13.8%
2,858,430 $295 Million
Q3 2022

Nov 10, 2022
SELL
$84.03 - $110.23 $38.5 Million - $50.5 Million
-457,785 Reduced 13.8%
2,858,430 $295 Million
Q2 2022

May 14, 2024
BUY
$78.08 - $117.61 $226 Million - $340 Million
2,893,361 Added 684.25%
3,316,215 $308 Million
Q2 2022

Aug 15, 2022
BUY
$78.08 - $117.61 $122 Million - $184 Million
1,561,757 Added 89.02%
3,316,215 $308 Million
Q1 2022

May 16, 2022
BUY
$102.18 - $135.75 $174 Million - $231 Million
1,698,302 Added 3024.26%
1,754,458 $206 Million
Q4 2021

Feb 14, 2022
BUY
$127.1 - $169.66 $3.2 Million - $4.27 Million
25,188 Added 81.34%
56,156 $7.56 Million
Q3 2021

Nov 10, 2021
BUY
$112.67 - $176.92 $3.49 Million - $5.48 Million
30,968 New
30,968 $4.94 Million

Others Institutions Holding ASND

# of Institutions
243
Shares Held
58.8M
Call Options Held
250K
Put Options Held
377K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.24B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email